These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 12702698)

  • 1. Development of the quinolones.
    Andersson MI; MacGowan AP
    J Antimicrob Chemother; 2003 May; 51 Suppl 1():1-11. PubMed ID: 12702698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent 6-desfluoro-8-methylquinolones as new lead compounds in antibacterial chemotherapy.
    Cecchetti V; Fravolini A; Palumbo M; Sissi C; Tabarrini O; Terni P; Xin T
    J Med Chem; 1996 Dec; 39(25):4952-7. PubMed ID: 8960555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety.
    Emami S; Foroumadi A; Faramarzi MA; Samadi N
    Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of (3S)-amino-(4R)-ethylpiperidinyl quinolones as potent antibacterial agents with a broad spectrum of activity and activity against resistant pathogens.
    Hu XE; Kim NK; Gray JL; Almstead JI; Seibel WL; Ledoussal B
    J Med Chem; 2003 Aug; 46(17):3655-61. PubMed ID: 12904069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship of quinolone antibacterial agents: the effects of C-2 substitution.
    Chu DT; Lico IM; Claiborne AK; Plattner JJ; Pernet AG
    Drugs Exp Clin Res; 1990; 16(5):215-24. PubMed ID: 1964116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New quinolone antibiotics: a survey of the literature from 2005 to 2010.
    Wiles JA; Bradbury BJ; Pucci MJ
    Expert Opin Ther Pat; 2010 Oct; 20(10):1295-319. PubMed ID: 20645884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinolone antimicrobial agents: structure-activity relationships.
    Zhang MQ; Haemers A
    Pharmazie; 1991 Oct; 46(10):687-700. PubMed ID: 1803382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antibacterial activity of new 7-piperazinyl-quinolones containing a functionalized 2-(furan-3-yl)ethyl moiety.
    Foroumadi A; Mohammadhosseini N; Emami S; Letafat B; Faramarzi MA; Samadi N; Shafiee A
    Arch Pharm (Weinheim); 2007 Jan; 340(1):47-52. PubMed ID: 17206610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New agents in development for the treatment of bacterial infections.
    Abbanat D; Morrow B; Bush K
    Curr Opin Pharmacol; 2008 Oct; 8(5):582-92. PubMed ID: 18761107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quinolones: historic review].
    Rothlin RP
    Medicina (B Aires); 1999; 59 Suppl 1():3-7. PubMed ID: 10436548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel antibacterial 8-chloroquinolone with a distorted orientation of the N1-(5-amino-2,4-difluorophenyl) group.
    Kuramoto Y; Ohshita Y; Yoshida J; Yazaki A; Shiro M; Koike T
    J Med Chem; 2003 May; 46(10):1905-17. PubMed ID: 12723953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationship of 7-(substituted)-aminomethyl-4-quinolone-3-carboxylic acid derivatives.
    Zhang Z; Yu A; Zhou W
    Bioorg Med Chem; 2007 Dec; 15(23):7274-80. PubMed ID: 17826097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure--activity relationship of quinolones.
    Toma E
    Clin Invest Med; 1989 Feb; 12(1):7-9. PubMed ID: 2537697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antibacterial activity of 7-(1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-7-yl) quinolones.
    Zhu B; Marinelli BA; Goldschmidt R; Foleno BD; Hilliard JJ; Bush K; Macielag MJ
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4933-6. PubMed ID: 19646867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis and antibacterial activity of 7-(3-amino-4-alkoxyimino-1 -piperidyl) -quinolones].
    Wang XY; Guo Q; Wang YC; Liu BQ; Liu ML; Sun LY; Guo HY
    Yao Xue Xue Bao; 2008 Aug; 43(8):819-27. PubMed ID: 18956774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, structure-activity relationship and antibacterial activity series of novel imidazo fused quinolone carboxamides.
    Reddy GV; Kanth SR; Maitraie D; Narsaiah B; Rao PS; Kishore KH; Murthy US; Ravi B; Kumar BA; Parthasarathy T
    Eur J Med Chem; 2009 Apr; 44(4):1570-8. PubMed ID: 18775585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Origins of the Quinolone Class of Antibacterials: An Expanded "Discovery Story".
    Bisacchi GS
    J Med Chem; 2015 Jun; 58(12):4874-82. PubMed ID: 25738967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial agents (oxazolidinones, quinolones, macrolides and new agents): patent highlights June to December 2000.
    Phillips OA; Matowe WC
    Curr Opin Investig Drugs; 2001 Jun; 2(6):745-51. PubMed ID: 11572651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2-oxoethyl] and N-[(2-5-bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones.
    Foroumadi A; Emami S; Mehni M; Moshafi MH; Shafiee A
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4536-9. PubMed ID: 16115766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.